PriMera Scientific Surgical Research and Practice (ISSN: 2836-0028)

Book-Review

Volume 8 Issue 2

Management of Dermatological Conditions

Christina Rahm*

August 04, 2026

View PDF

Abstract

The epidermis, being the largest organ within the human body, functions as the primary protective barrier against a multitude of environmental threats, heavy metals, viruses, and infections. Currently, the level of technological advancement is inadequate to effectively provide a diverse array of items, such as biotechnology-based therapies, lubricants, vitamins, nutraceuticals, and pharmaceuticals.

Moreover, it has constraints in its ability to effectively monitor and discern the specific requirements of the epidermis. Despite being exposed to ideal conditions, the epidermis exhibits significant deficiencies in a number of critical characteristics, including pH regulation, conductivity, resistance to solvents, water, and chemicals, flexibility, and durability (Telange et al. 2022). Currently under review is an epidermal coating concept, referred to as the “Nanotechnology Super Skin Coating,” which is in the patent-pending evaluation phase. This innovation serves as a primary defense mechanism that effectively mitigates potential risks, including but not limited to infectious diseases, hazardous heavy metals, and environmental pollutants. The epidermal coating generation process involves the controlled integration of iron oxide nanoparticles with a solution containing citric acid, stabilized ionic silver, and nano-sized zeolite. This proprietary technique, developed by Dr. Rahm, enables the formation of conductive nano-mesh architectures within sensor systems, yielding materials with exceptional properties, including ultra-thin profile, high flexibility, fire resistance, gas permeability, lightweight structure, and enhanced structural integrity with minimal defect potential. Over the past few years, significant technological progress has enabled the epidermis to evolve into an autonomous wireless system with the ability to detect, identify, and eradicate a diverse array of infections. Pathogens comprise an extensive array of origins, including microorganisms, heavy metals, radioactive debris, organic substances, and pesticides and herbicides. These deleterious substances are recognized for their ability to accelerate the aging process and impede the progression of diseases through the promotion of skin tissue regeneration.

References

  1. Bajgai J., et al. “Role of molecular hydrogen in skin diseases and its impact on beauty”. Current Pharmaceutical Design 27.5 (2021).
  2. Holte K and McIntyre G. “The Skin (Integument): Part II—Dermatological diseases commonly seen in the head and neck”. Diseases and Injuries to the Head, Face and Neck (2021): 1625-1683.
  3. Husein-Ahmed H and Steinhoff M. “Laser and light-based therapies in the management of rosacea: An updated systematic review”. Lasers in Medical Science 36 (2021): 1151-1160.
  4. Kuchekar AB., et al. “Psoriasis: A comprehensive review”. International Journal of Pharmacy & Life Sciences 2.6 (2011): 857-877.
  5. Lee JW., et al. “Deciphering UV-induced DNA damage responses to prevent and treat skin cancer”. Photochemistry and Photobiology 96.3 (2020): 478-499.
  6. Leung AK., et al. “Pityriasis rosea: An updated review”. Current Pediatric Reviews 17.3 (2021): 201-211.
  7. Łukaszewska-Kuska M., et al. “The effectiveness of topical forms of dexamethasone in the treatment of oral lichen planus—A systematic review”. Oral Diseases 28.8 (2022): 2063-2071.
  8. Meretskyi V and Meretska I. “Principles of effective use of non-steroidal anti-inflammatory drugs”. Inter Collegas 10.1 (2023).
  9. Molinell E., et al. “Metabolic, pharmacokinetic, and toxicological issues surrounding dapsone”. Expert Opinion on Drug Metabolism & Toxicology 15.5 (2019): 367-379.
  10. Schleicher SM and Vlahovic TC. “Skin signs of systemic disease and reactive disorders of the lower extremity”. Atlas of Lower Extremity Skin Disease (2022): 71-76.
  11. Thandar Y., et al. “Treatment of cutaneous lichen planus (Part 1): A review of topical therapies and phototherapy”. Cogent Medicine 6.1 (2019).
  12. Leung AK., et al. “Pityriasis rosea: An updated review”. Current Pediatric Reviews 17.3 (2021): 201-211.
  13. Zhang H., et al. “Rosacea treatment: Review and update”. Dermatology and Therapy 11 (2021): 13-24.
  14. Alkhatib B, Alhilo I and Alhilo S. “Psoriasis management using herbal supplementation: Retrospective clinical case-study”. Alternative Therapies in Health and Medicine (2021).
  15. Alkeswani A, Cantrell W and Elewski B. “Treatment of tinea capitis”. Skin Appendage Disorders 5.4 (2019): 201-210.
  16. Cullen JK., et al. “Topical treatments for skin cancer”. Advanced Drug Delivery Reviews 153 (2020): 54-64.
  17. Daniyal M., et al. “Progress and prospects in the management of psoriasis and developments in phyto-therapeutic modalities”. Dermatologic Therapy 32.3 (2019): e12866.
  18. Eichenfield DZ, Sprague J and Eichenfield LF. “Management of acne vulgaris: A review”. JAMA 326.20 (2021): 2055-2067.
  19. Gaikwad RG, Shinde AJ and Hajare AA. “Herbal treatment for management of psoriasis: An overview”. Research Journal of Pharmacy and Technology 15.3 (2022): 1385-1392.
  20. Mansoori B., et al. “Photodynamic therapy for cancer: Role of natural products”. Photodiagnosis and Photodynamic Therapy 26 (2019): 395-404.
  21. Mandlik DS and Mandlik SK. “Atopic dermatitis: New insight into the etiology, pathogenesis, diagnosis and novel treatment strategies”. Immunopharmacology and Immunotoxicology 43.2 (2021): 105-125.
  22. Izah SC., et al. “Historical perspectives and overview of the value of herbal medicine”. Herbal Medicine Phytochemistry: Applications and Trends (2023): 1-33.
  23. Kaushik K and Agarwal SHWETA. “The role of herbal antifungal agents for the management of fungal diseases: A systematic review”. Asian Journal of Pharmaceutical and Clinical Research 12.7 (2019): 34-40.
  24. Leung AK., et al. “Tinea capitis: An updated review”. Recent Patents on Inflammation & Allergy Drug Discovery 14.1 (2020): 58-68.
  25. Patel B, Kothari V and Acharya N. “Mainstreaming traditional practices for wound management”. Wound Healing Research: Current Trends and Future Directions (2021): 219-245.
  26. Pattinson R., et al. “Development of a conceptual framework for a Patient-Reported Impact of Dermatological Diseases (PRIDD) measure: A qualitative concept elicitation study”. Acta Dermato-Venereologica 102 (2022): adv00823.
  27. Qadir A., et al. “Drug delivery of natural products through nano-carriers for effective vitiligo therapy: A compendia review”. Journal of Cosmetic Dermatology 21.11 (2022): 5386-5404.
  28. Shakhbazova A., et al. “A systematic review of nutrition, supplement, and herbal-based adjunctive therapies for vitiligo”. The Journal of Alternative and Complementary Medicine 27.4 (2021): 294-311.
  29. Sharifi-Rad J., et al. “Natural products and synthetic analogs as a source of antitumor drugs”. Biomolecules 9.11 (2019): 679.
  30. Sharma A and Gupta S. “Protective manifestation of herbonanoceuticals as antifungals: A possible drug candidate for dermatophytic infection”. Health Science Reports 5.5 (2022): e775.
  31. Telange DR, Ganorkar SB and Shirkhedkar AA. “Herbal bioactives for treating infectious skin diseases”. Herbal Drugs for the Management of Infectious Diseases (2022): 263-289.
  32. Woo TE., et al. “Diagnosis and management of cutaneous tinea infections”. Advances in Skin & Wound Care 32.8 (2019): 350-357.
  33. Xu M., et al. “A network pharmacology approach to uncover the molecular mechanisms of herbal formula Kang-Bai-Ling for treatment of vitiligo”. Evidence-Based Complementary and Alternative Medicine (2019).
  34. Yan F., et al. “The formulae and biologically active ingredients of Chinese herbal medicines for the treatment of atopic dermatitis”. Biomedicine & Pharmacotherapy 127 (2020): 110142.